about us
mission
Improving quality of life by substantially alleviating severe and debilitating effects of rare diseases with high unmet need.
Rezolute is dedicated to developing transformative therapies, and our focus is on substantially improving the quality of life for individuals living with hyperinsulinism (HI) by alleviating the burden of severe and debilitating hypoglycemia.
“We are caregivers, loved ones, and patients. The spectrum of our humanity informs and inspires everything that we do in our mission to develop therapies that will make a difference.”
We imagine a different world – one where patients no longer live in fear of unpredictable, life-threatening hypoglycemic lows, and families obtain greater control over their lives.
With two rare disease Phase 3 programs underway in congenital and tumor HI and compelling real-world outcomes from our Expanded Access Program, we are getting closer to making that world a reality.